Remdesivir in COVID-19: Indication of considerable added benefit for some patients
Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but ...
Jul 6, 2021
0
5